Physician profile
Bryan S Lee
NPI 1437336609
$16,226.39
in general payments reported to CMS, 2019-2025
19 companies · $1,125 in 2025
The $1,125 reported for 2025 was more than what 80% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,669 · 2020: $125 · 2021: $879 · 2022: $1,308 · 2023: $3,084 · 2024: $2,038 · 2025: $1,125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,225 · Food and Beverage: $1,021.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,225.00 |
| Food and Beverage | $1,021.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $4,490.24 | 2019-2025 | Cirrus Hd-Oct, Visumax, Quatera 700 |
| Johnson & Johnson Surgical Vision, INC. | $3,807.85 | 2019-2024 | Tecnis Simplicity, Intralase Fs Femtosec Laser, Ifs Advanced Femtosec Laser |
| Alcon Vision LLC | $3,524.29 | 2019-2024 | Hydrus Microstent |
| Aerie Pharmaceuticals, INC. | $1,579.85 | 2019-2021 | |
| New World Medical,INC. | $1,097.98 | 2021-2024 | Kahook Dual Blade, Ahmed Glaucoma Valve, Clearpath |
| Lensar, INC. | $700.00 | 2021 | |
| Carl Zeiss Meditec USA, INC. | $296.12 | 2022-2023 | Quatera 700, Iolmaster 700 |
| Sun Pharmaceutical Industries INC. | $152.92 | 2019-2020 | |
| Dompe US, INC. | $139.31 | 2024 | Oxervate |
| Kala Pharmaceuticals, INC. | $130.08 | 2019-2022 | |
| Biotissue Holdings INC. | $92.06 | 2021-2023 | |
| Carl Zeiss Meditec Production LLC | $69.03 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $42.46 | 2020-2021 | |
| Alphatec Spine, INC | $24.33 | 2022 | |
| Abbvie INC. | $24.20 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $24.04 | 2022 | |
| Omeros Corporation | $18.94 | 2020 | |
| Iridex Corporation | $12.69 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.